Skip to Main Content

Contribute Try STAT+ Today

Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

red & yellow pill chart drug price controls

Pharmalot By Ed Silverman

Just how many barriers do health insurers create to fair access to medicines?

“There’s a lot of nuance to this report,” ICER's Steve Pearson told us. “Around 25% of the time we couldn’t find what we were looking for."

Oxycontin protest - pill bottles

Pharma By Geoff Mulvihill — Associated Press

States: Sackler family members abusing bankruptcy process

Pharmalot By Ed Silverman

Pharmalittle: Moderna CEO cautions Covid shots will be less effective against Omicron; Pfizer predicts new vaccine for the variant in 100 days

Pharmalot By Ed Silverman

McDonald’s accused of dragging its feet on goal of reducing antibiotic use in beef supplies

3 syringes

Pharmalot By Ed Silverman

The Omicron variant underscores the global stakes of Covid-19 vaccine inequity

All Coverage

medication overload

Pharmalot By Ed Silverman

Amgen joins a growing list of drug makers cutting discounts to safety-net hospitals

Pharmalot By Ed Silverman

Pharmalittle: Merck Covid pill squeaks past FDA panel; analysis explores whether insurers give ‘fair access’ to drugs

advertisement

Stock exchange

Pharmalot By Ed Silverman

Socially responsible investor coalitions push greater access to medicines in shareholder proposals

Pharmalot By Ed Silverman

Pharmalittle: Vaccine makers scramble to assess the Omicron Covid strain; Pfizer to step up Covid pill production

Pharmalot By Ed Silverman

Pfizer sues former employee for allegedly stealing Covid-19 vaccine documents

Pharmalot By Andrew Joseph

Pharmalittle: Jury finds pharmacy chains recklessly distributed opioids; FDA choice Califf has millions invested in pharma

Pharmalot By Rachel Cohrs

Pharmalittle: Aduhelm study shows brain swelling in one-third of patients; Americans may struggle to access Covid antivirals

Pharmalot By Damian Garde

Pharmalittle: CDC endorses Covid-19 boosters for all adults; investors pressure Novartis to spend cash reserves

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharma By Ed Silverman

Pharmalittle: FDA expands emergency use for Pfizer and Moderna Covid boosters; Biden move to lower drug prices would save U.S. $160 billion

Ambulance

Pharmalot By Ed Silverman

Can local governments convince the courts that opioid makers and wholesalers caused a public nuisance?

Emma Walmsley

Pharma By Kate Sheridan

GlaxoSmithKline’s Emma Walmsley predicts a ‘landmark’ 2022 for the company

Worldwide Covid-19 vaccinations

Pharmalot By Ed Silverman

Proposal to waive intellectual property rights for Covid-19 vaccines and drugs appears unlikely to pass

antibiotics/teal background

Pharmalot By Ed Silverman

A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds

Pharmalot By Ed Silverman

Pharmalittle: SEC probes Cassava over Alzheimer’s drug results; Teva takes pharma in a new direction with a bond sale

Pharmalot By Ed Silverman

By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction

Biden Covid brief.

Pharmalot By Ed Silverman

‘Late is better than never’: Biden plan to boost U.S. production of Covid vaccines gets mixed reviews

Biogen - 2015 exterior

Pharmalot By Ed Silverman

‘Can’t get much worse’: What a European rejection of an Alzheimer’s drug would mean for Biogen

FDA sign FDA commissioner

Pharmalot By Ed Silverman

FDA is urged to disqualify a hospital review board and two doctors over clinical trial missteps

Pharmalot By Ed Silverman

Pharmalittle: European regulators unlikely to approve Biogen Alzheimer’s drug; U.S. to invest billions to expand Covid vaccine production

Optum

Pharmalot By Ed Silverman

‘Where’s my prescription?’: California wants to revoke an OptumRx pharmacy license for prescribing lapses

Pfizer Albert Bourla

Pharmalot By Ed Silverman

Pfizer to file for emergency authorization Tuesday for its Covid-19 pill

Pharmalot By Ed Silverman

Pharmalittle: Biogen R&D chief retiring amid controversy over Alzheimer’s drug; Pfizer strikes deal for generic versions of its Covid pill

drug prices on the rise

Pharmalot By Ed Silverman

The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.6 billion in 2020